XML 63 R50.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Reporting - Schedule of Segment Revenue and Operating Income (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Segment Reporting Information [Line Items]        
Revenues $ 762.1 $ 667.6 $ 1,479.5 $ 1,333.8
Adjusted EBITDA 118.3 100.2 215.8 190.3
Reconciliation of Adjusted EBITDA:        
Income before income taxes 33.3 49.9 62.0 49.5
Net income attributable to non-controlling interests (43.9) (38.8) (80.6) (64.9)
Interest expense, net 51.5 47.7 98.8 94.5
Depreciation and amortization 34.8 24.4 68.5 58.1
Equity-based compensation expense 15.1 4.6 20.0 8.8
Transaction, integration and acquisition costs 20.8 13.0 39.7 25.8
Net loss (gain) on disposals, consolidations and deconsolidations 5.3 (8.8) 6.8 1.7
Litigation settlements and regulatory change impact 1.1 1.7 (0.1) 9.7
Loss on debt extinguishment 5.1 0.0 5.1 0.0
Undesignated derivative activity 0.0 0.0 0.0 0.6
Other (4.8) 6.5 (4.4) 6.5
Transaction and integration costs 19.3 12.0 36.7 24.5
Start-up costs 1.5 1.0 3.0 1.3
(Loss) gain on litigation settlement (0.5) (1.5) 1.3 (4.5)
Other litigation costs 0.6 0.2 1.2 0.8
Additional interest expense for Florida LOP regulation change       4.4
Operating Segments | Surgical Facility Services        
Segment Reporting Information [Line Items]        
Revenues 730.4 650.2 1,423.1 1,299.2
Adjusted EBITDA 143.0 126.7 269.7 245.5
Operating Segments | Ancillary Services        
Segment Reporting Information [Line Items]        
Revenues 31.7 17.4 56.4 34.6
Adjusted EBITDA 0.1 (0.1) (1.3) (1.5)
All other        
Segment Reporting Information [Line Items]        
Adjusted EBITDA $ (24.8) $ (26.4) $ (52.6) $ (53.7)